Greetings and welcome to the Relmada Therapeutics Incorporated quarter four 2024 financial results call. Good day, everyone and thank you for joining us today. This afternoon, Relmada issued a press ...

Planegg-Martinsried, Germany - Formycon AG (FSE: FYB, “Formycon”) today published its audited consolidated financial statements for the 2024 financial year and provided an outlook for fiscal year 2025 ...

James Ratcliffe; Vice President of Investor Relations; Telesat Corp. Daniel Goldberg; President, Chief Executive Officer, Director; Telesat Corp. Andrew Browne; Chie ...

Dr. Stefan Glombitza, CEO of Formycon AG, said: “2024 was a year marked by significant milestones for Formycon and substantial progress in our product pipeline ... Our entire pipeline continues to ...

According to data from OpenInsider, stocks with concentrated insider buying activity have historically outperformed the ...

Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...

Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety ...

Vice President, Global Communications and Culture Hello, everyone, and thank you for joining us for the CarParts.com fourth ...

Operator Greetings and welcome to the 3D Systems fourth quarter and fiscal year 2024 earnings conference call and webcast. At ...

Another long-term benefit of embracing sustainable innovation now is mitigating the growing risks associated with climate ...

Q4 2024 Earnings Conference Call March 27, 2025 10:00 AM ETCompany ParticipantsJames Ratcliffe - VP, IRDan Goldberg ...